2014 Annual Meeting | 2MS.003 - Global Health Challenges: Neurology in Developing Countries

��ɫ��

2014 Annual Meeting | 2MS.003 - Global Health Challenges: Neurology in Developing Countries

Date Sunday 04/19/15

Time 06:30 AM - 08:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Morning Seminar

Director(s) James H. Bower, MD, MSc, FAAN

Topic(s) General Neurology

Learning Objectives Participants should be able to identify the leading contributors to the global burden of neurological disorders, describe the epilepsy treatment gap in different regions of the world, and understand the role of international organizations in the prevention, care, and treatment of neurological disorders.

CME Available 0.00 credit

Core Competencies Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Didactic

Event Timeline
06:30 AM - 07:00 AM		The Global Burden of Neurological Diseases Jerome H. Chin, MD, PhD, MPH, FAAN
07:00 AM - 07:30 AM		The Epilepsy Treatment Gap Ana-Claire L. Meyer, MD, FAAN
07:30 AM - 08:00 AM		Neurology and International Organizations Farrah J. Mateen, MD, PhD, FAAN

Faculty Disclosures
James H. Bower, MD, MSc, FAAN	The institution of Dr. Bower has received research support from Abbvie.
Jerome H. Chin, MD, PhD, MPH, FAAN	Dr. Chin has received publishing royalties from a publication relating to health care.
Farrah J. Mateen, MD, PhD, FAAN	Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Ana-Claire L. Meyer, MD, FAAN	Dr. Meyer has received personal compensation for serving as an employee of Denali Therapeutics.

��ɫ����

��ɫ����

��ɫ��

��ɫ��